Antigen stimulation of cultured bone-marrow-derived mast cells sensitized with specific monoclonal IgE induced cell degranulation and paf-acether (paf; 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) biosynthesis via the deacylation/ acetylation (remodelling) pathway. Phorbol myristate acetate (PMA; 20-100 ng/ml) triggered only acetyltransferase activation, without concomitant lyso-paf (l-O-alkyl-sn-glycero-3-phosphocholine) and paf formation. A low concentration of PMA (5 ng/ml) potentiated antigen-induced degranulation, acetyltransferase activation and paf formation by about 30%,biat did t hlevel of lyso-paf formation. Stimulation of mast cells with antigen increased intracdllh1ar Ca2+ from 61 to 269 nm, whereas no modification of Ca2+ influx was observed wMhen cells were pretreated with PMA (5 ng/ml) before antigen challenge. Gas chromatography coupled to electron capture detection revealed that the composition of paf formed by cells stimulated by antigen alone was similar to that ofpaf formed by PMA-primed antigenstimulated cells; 84 + 8 % and 79 + 2 % (means+ S.E.M., n = 3) of molecules respectively bore the C16 0 alkyl chain moiety, with the remainder bearing essentially C18:0 molecules. Overnight treatment of mast cells with PMA (200 ng/ml) caused disappearance of protein kinase C (PKC) from both cytosol and membranes. When such cells were stimulated further with antigen, they failed to degranulate, and acetyltransferase activation, paf production and lyso-paf production were decreased by 33 + 11 %, 57 +4% and 96 + 3 % respectively (n = 3 or 5). The PKC inhibitors chlorpromazine and staurosporine inhibited to a significant extent both cell degranulation and all steps leading to paf biosynthesis. Our data suggest that PKC-dependent mechanisms are operational during cell degranulation and contribute only in part to paf biosynthesis. The PKC-dependent signal directly generated by PMA or diacylglycerol is not sufficient to trigger the full cell response, which is obtained only through receptor-operated antigen challenge.
INTRODUCTION
It has been substantiated that the biosynthesis of paf-acether [paf; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (1-O-alkyl-2-acetyl-GPC)] in stimulated pro-inflammatory cells is regulated by the level and the degree of activation of l-O-alkyl-GPC: acetylCoA acetyltransferase (EC 2.3.1.67) (reviewed in [1, 2] ). This tightly membrane-bound enzyme [3] [4] [5] is present in its 'pro' form in unstimulated cells [6] and is phosphorylated into the active form during specific cell stimulation [7] . It has been shown that mouse bone-marrow-derived mast cells passively sensitized with the monoclonal IgE anti-[dinitrophenyl (DNP)-BSA] were able to form paf [8] and to release the granular enzyme fl-N-acetylhexosaminidase (fl-Hex) during antigen challenge [9] . We correlated this antigen-induced paf formation with the activation of acetyltransferase, i.e. phosphorylation of the enzyme, and we showed that the treatment of cells with the protein kinase C (PKC) activator phorbol myristate acetate (PMA) increased acetyltransferase activity [7] .
The membrane PKC activity is markedly increased after antigen challenge of the mast cell line PT-18 [10] . We show here that antigen challenge of cultured mast cells induces a rapid loss of cytosolic PKC, concomitant with the appearance of membrane-bound enzyme. Thus we compared paf biosynthesis and fl-Hex release (as an index of mast cell degranulation) triggered by either PMA or the diacylglycerol analogue 1,2-dioctanoyl-sn-glycerol (DAG) associated or not with antigen. We demonstrated a lack of paf formation and fl-Hex release during PMA challenge; by contrast, treatment of mast cells with a low concentration ofPMA before antigen challenge potentiated paf formation, acetyltransferase activation and f-Hex release. To assess the role of PKC during antigen challenge, mast cells were cultured for 18-24 h with PMA and paf biosynthesis was immunologically triggered. Our results suggest that PKC is required in signal transduction leading to fl-Hex release, but only in part for paf synthesis, in immunologically stimulated mast cells.
This work has been presented in part as a preliminary report at the 71st Annual Meeting of The Federation of American Societies for Experimental Biology (Washington, DC, 29 March-2 April 1987) [11] .
MATERIALS AND METHODS

Reagents
The following reagents were obtained as from the sources given: fetal calf serum, RPMI 1640, non-essential amino acids, Abbreviations used: fl-Hex, fl-N-acetyl-hexosaminidase; DAG, 1,2-dioctanoyl-sn-glycerol; GPC, sn-glycero-3-phosphocholine; paf, paf-acether (l-O-alkyl-2-acetyl-GPC; originally described as platelet-activating factor); paf-C16 0, 1-O-hexadecyl-2-acetyl-GPC; paf-C18.0, 1-O-octadecyl-2-acetyl-GPC; lyso-paf, l-O-alkyl-GPC; lyso-paf-C16:0, l-O-hexadecyl-GPC; lyso-paf-C18:0, l-O-octadecyl-GPC; PDD, 4a-phorbol 12,13-didecanoate; PMA, 4,f-phorbol 12 [12] and stored at -20 'C. The concentration of DNP-BSA and the extent of substitution (DNP13-BSA) were calculated using the molar absorption coefficient of DNP-L-lysine at 360 nm (17 350) [12] . The monoclonal DNPspecific IgE-secreting hybridoma (line 2682-1) was grown as ascites as in [13] .
Bone-marrow-derived mast cells
Bone marrow cells from tibias and femurs of BALB/c mice (Iffa Credo, L'Arbresle, France) were cultured in a 1: 1 (v/v) mixture of conditioned medium and RPMI supplemented with 10% (v/v) fetal calf serum, 0.1 mm non-essential amino acids, 2 mM-L-glutamine, 50 4uM-2-mercaptoethanol, 50 units of penicillin/ml and 50 jug of streptomycin/ml (enriched medium) [14] . The conditioned medium used for the differentiation of bone marrow cells into mast cells was the supernatant of 2-day mixed lymphocyte cultures (C57BL6/C3H/He) performed in the presence of 2 ,ug of concanavalin A/ml as in [14] . Cells were passaged weekly, and by 21 [17] , as modified by Vilgr-ain et al. [18] . Briefly, mast cells (1.4 x 107) were homogenized in 500 pl of ice-cold buffer (25 mM-Tris/HCI, pH 7.5, 2 mM-EDTA, 10 mM-EGTA, 0.25 Msucrose, 2 mM-DTT and 50 ,ug of leupeptin/ml) using a PotterElvehjem instrument with a Teflon pestle. The homogenate was centrifuged at 105 000 g for 45 min at 4 'C. After centrifugation, the supernatant (cytosol) and the pellet (membranes) were used for enzymic studies. For the PKC assay in the particulate fraction, the 105000 g pellet was resuspended in 50 ,ll of homogenization buffer containing 0.5 % Triton X-100 at 4 'C for 30 min and then centrifuged at 10000 g for 10 min. The cytosol and the pellet extract were applied to a DEAE-cellulose column (200 #l) previously equilibrated with Tris/DTT buffer (20 mMTris/HCl, pH 7.5, 2 mM-EDTA, 2 mM-EGTA, 1 mM-DTT and 2 % glycerol). After a column wash with 1 ml of the same buffer, the PKC was eluted with 400 u1 of Tris/DTT buffer containing 0.2 M-NaCl. The enzyme activity was assayed by measuring the transfer of 32p from [y-32P]ATP to lysine-rich histone H1. The reaction mixture (80,1) contained 0.01 mM-[32P]ATP (specific radioactivity 1000 c.p.m./pmol), 20 ,tg of histone/ml, 10 mmMgCl2 and 0.75 mM-CaCI2. Phosphatidylserine (13,ug) and diolein (0.8 jug) were included or not in the assay, as indicated, using a lipid suspension in 100 mM-Tris/HCl, pH 7.5, previously sonicated at 30 'C for 5 min. The reaction was carried out at 30 'C for 10 min and stopped by addition of 12 % trichloroacetic acid in the presence of casein (900,ug) as a carrier. The protein precipitate was dissolved in 1 M-NaOH, and 32p incorporation was measured by scintillation counting in Aquasol with a Kontron SL 3000 spectrometer.
Measurement of intracellular Ca2+ (ICa21ji
[Ca2+]1 was measured by using the Ca21 indicator fura-2 as described by Grynkiewicz et al. [19] . Mast cells were loaded with 1 1sM-fura-2/AM for 30 min in Tyrode's buffer containing 0.25 % BSA. Cells were then centrifuged and resuspended in the same buffer. Fluorescence measurements were performed at 37 'C in 1 ml mast cell samples with a spectroftuorophotometer (model RF-5000; Shimadzu, Kyoto, Japar), after addition of agonist, by the dual-wavelength (340 and 380 nm) excitation method.
Cytoplasmic free Ca2l concentrations were determined according to the ratio method [19] .
Paf and lyso-paf assay and characterization Paf content was measured by the rabbit platelet aggregation assay [20, 21] by comparison with known amounts of synthetic paf. Rabbit platelets were treated with 0.1 mM-aspirin for 15 min at room temperature to avoid aggregation due to contaminating arachidonic acid. Aggregation was carried out in the presence of the ADP scavenger complex phosphocreatine (0.7 mM)/creatine kinase (13.9 units/ml). Paf content was calculated using a calibration curve established with synthetic paf. Results are expressed as pmol of paf/106 mast cells. The specific paf antagonist BN 52021 ( [22] , Institut Henri Beaufour, Le PlessisRobinson, France) inhibited platelet aggregation induced by cell ethanolic extracts. Lyso-paf was measured after chemical acetylation into paf [23] . Briefly, dry ethanolic residues were incubated overnight with 200 #1 of pyridine and 200 ,ul of acetic anhydride. Pyridine was then eliminated by mixing the samples with 1 ml of dichloromethane. The samples were dried and the procedure was repeated twice; the dry residue was suspended in 150 mM-NaCl supplemented with 0.25 % BSA or 60 % ethanol and assayed for paf activity using the bioassay as described above.
In selected experiments, paf and lyso-paf were analysed by gas chromatography electron capture detection. Paf and lyso-paf isolated from cells were purified by h.p.l.c. prior to the digestion with phospholipase C from Clostridium welchii. The resulting 1-O-alkyl-2-acetyl-sn-glycerol-and 1-O-alkyl-sn-glycerol-species were converted into heptafluorobutyrate derivatives [24] , which were dissolved in toluene and analysed by gas chromatography using an OV-1 fused capillary column (25 m «1-Hex assay fl-Hex was measured in supernatants and sonicated cell pellets by monitoring the hydrolysis of p-nitrophenyl N-acetyl-fl-Dglucosaminide, as described in [25] . The net percentage f-Hex release was calculated using the following formula: (Fig. la) and lyso-paf (Fig. lb) formation, acetyltransferase activation (Fig. Ic) and ,-Hex release (Fig. 2a) . In contrast, when the cells were stimulated with PMA (100 ng/ml), only the acetyltransferase activity was augmented (Fig. lc) ; neither formation of paf (Fig. la) or lysopaf (Fig. lb) (Fig. la) . In 11 experiments, this maximal amount of paf formed at 5 min was 23 + 3 pmol/lOff cells (mean + S.E.M.). In some experiments, PMA concentrations were varied between 5 and 50 ng/ml, but no f-Hex release or paf formation was observed (results not shown). Next we examined the time course of the synthesis of lyso-paf, the direct precursor of paf (Fig. lb) . The level of lyso-paf varied in unstimulated cells from 11 to 90 pmol/106 cells (35 +7 pmol/106 cells; mean+s.E.M., n = 11).
When mast cells were stimulated with 100 ng of PMA/ml (and also with between 5 and 50 ng/ml; results not shown) relatively minor changes in the initial total lyso-paf content were observed (Fig. lb) . By contrast, following antigen stimulation, lyso-paf content increased between 1 min and 30 min. The apparent decrease observed between 3 and 5 min was not significant (by Wilcoxon test). However, we observed that the level of lyso-paf had diminished at 5 min in 9 out of 23 experiments and at 3 min in 6 out of 13 experiments.
In three separate experiments, stimulation of mast cells with PMA (100 ng/ml) for 15 min in the presence of lyso-paf [100 nM- Mast cells (I x 10' in 0.5 ml) were stimulated with the -concentrations of DAG given for IO min at 37 'C. (Fig. 2b) and release of c-Hex (Fig. 2a) contrast, the lyso-paf level was not modified by PMA pretreatment as compared to that obtained after antigen challenge alone (Table 1) . These results suggest that there is a common step for acetyltransferase stimulation via antigen and PMA and that the increase in acetyltransferase activity is possibly the limiting factor in paf biosynthesis, as proposed previously [26] .
Changes in ICa2+lI during cell stimulation Changes in [Ca2+]1 were monitored using the fluorescent probe fura-2 in three independent experiments. When passively sensitized and fura-2/AM-loaded mast cells were challenged with Changes in PKC activity in stimulated mast cells
The translocation of PKC from the cytosol to the plasma membranes observed during antigen challenge was used as an indicator of PKC activation. Unstimulated mast cells possessed a larger amount of cytosolic than membrane PKC ( Table 2) . Stimulation of mast cells with antigen (40 ng/ml) for 5 min induced a shift of the PKC activity from the cytosol to the membranes. Overnight treatment of cells with PMA (200 ng/ml) induced a total depletion of PKC activity in both cytosol and membranes. Antigenically induced acetyltransferase activation, paf formation and lyso-paf formation were inhibited by 33 + 11 %, 57 + 4 % and 96 + 3 % (n = 3 or 5) respectively in the latter PMA-treated cells ( Table 2 ). The antigenically initiated release of fl-Hex by mast cells was completely abolished by PMA treatment. When the (overnight) PMA-treated cells were challenged with PMA (100 ng/ml) for 10 min, the stimulation of acetyltransferase was inhibited by 100% (n = 2). Also, two inhibitors of PKC, chlorpromazine (10 uM) and staurosporine (1 /M), were extremely efficient in blocking the antigenic stimulation of mast cells (Table 3) . Furthermore, the PMA (100 ng/ml)-induced activation ofacetyltransferase in intact mast cells was inhibited by 91 + 9 % (n = 3) by chlorpromazine (10 ,tM) . Treatment of cells with these drugs did not result in lactate dehydrogenase leakage into the medium, suggesting that cell viability was not affected (results not shown).
Vol. 271 Gas chromatography analysis of paf molecular species
Paf and lyso-paf species formed by cells stimulated with antigen alone or by PMA-primed and antigen-stimulated mast cells were analysed using gas chromatography (Table 4) . When sensitized mast cells were stimulated with antigen, the majority ofpaf contained C16: 0molecules, and only about 20 % of paf was composed of C18 0molecules (Fig. 4) . Traces ofthe Cl8: lanalogue 
DISCUSSION
As previously reported [7] , antigen challenge of mast cells induced fl-Hex release and acetyltransferase activation, i.e. phosphorylation of the enzyme and paf formation. PKC has been implicated in the acetyltransferase activation (phosphorylation) [7] . In the present study, we raised the question of the dependence of immunologically triggered paf formation on PKC activation, as shown in human neutrophils stimulated with a phagocytic stimulus [27] . Addition of PMA or of DAG, a synthetic analogue of endogenous diacylglycerol, the natural activator of PKC [28] , to intact cells resulted in an increase of acetyltransferase activity. To assess whether acetyltransferase activation was mediated via PKC, we substituted for PMA the structurally similar phorbol ester, PDD, which does not activate PKC. The latter was ineffective in increasing the level of acetyltransferase activity. From these results, we concluded that PKC could be involved in the signal transduction leading to phosphorylation of acetyltransferase in mast cells. However, this event was not associated with the formation of paf or with the modulation of lyso-paf content in the cell. Further evidence for PKC involvement in cell activation was the following. Threshold concentrations of PMA potentiated the response of antigen challenge, as judged by the potentiation of fl-Hex release and of the deacylation/acetylation pathway, i.e. acetyltransferase activation and paf formation. In contrast, we showed the absence of a priming effect of PMA on antigen-induced lyso-paf formation. The latter compound is the immediate precursor for paf biosynthesis via the acetyltransferase pathway. In a recent work, Nieto et al. [29] showed that PMA induced paf formation in human neutrophils de novo via a pathway involving DTTinsensitive CDP-choline choline phosphotransferase. In light of our results, this pathway was not operational in mast cells stimulated with phorbol ester.
Mobilization of intracellular Ca2+, as monitored by fluorescence probes, is detected very early after antigen challenge in basophils and mast cells, and appears to be one of the earliest intracellular changes after receptor bridging (reviewed in [30] Indirect activation of phospholipase A2 by PMA was described in intact neutrophils [31] , suggesting that this enzyme could be activated even in the absence of a Ca2+ signal. However, as pointed out above, we did not detect any change in the lyso-paf content after PMA challenge. This could suggest the importance of a Ca2+ signal in phospholipase A2 stimulation in mast cells.
Unstimulated mast cells contained PKC which was located mostly in the cytosol. Antigen challenge of the cells induced a decrease of PKC in the cytosol, accompanied by an increase of activity associated with membranes. The overnight treatment of mast cells with PMA induced a total loss of PKC activity in both cytosol and membranes and a partial decrease in cell responsiveness to antigen challenge, i.e. decreases in acetyltransferase activation and paf formation. The net gain of lyso-paf was, however, totally inhibited. These results suggest either that PKC is not the only enzyme implicated in the signal transduction leading to paf biosynthesis or that alternative pathways are switched on in the absence of PKC. However, inhibitors of PKC (chlorpromazine and staurosporine) inhibited totally cell degranulation and all steps leading to paf biosynthesis. The discrepancy that we observed between the data obtained with PKCdepleted cells and those obtained with PKC inhibitors may be due either to the non-specific action of the latter [32] or to the differential down-regulation by PMA of PKC subtypes [33] . It was postulated recently that the PKC isoform e does not phosphorylate histones [34] , the commonly used substrates in PKC assay. Thus it is difficult at this stage to confirm the total depletion of all PKC isoenzymes on overnight incubation with PMA.
Previous reports have shown that, in a cell-free system, the acetyltransferase from rat spleen and exocrine glands was phosphorylated by a commercial cyclic AMP-dependent protein kinase [35, 36] but not by a purified PKC [36] . It is possible, however, that connections exist between these two phosphorylation pathways, as discussed previously [37, 38] .
The molecular species of paf and lyso-paf formed by antigenstimulated or PMA-primed plus antigen-stimulated cells were very similar, suggesting that the same precursors were implicated in paf synthesis following both types of stimuli. Interestingly, in stimulated cells lyso-paf was composed of predominantly C16:0 molecules, in contrast with unstimulated cells, where equal quantities of C160 and C180 species were detected. This observation supports the idea of phospholipase A2 specificity towards l-O-hexadecyl-acyl-GPC or greater susceptibility of the latter to hydrolytic attack.
In conclusion, the present data allow us to consider PKC involvement in signal transduction during antigen challenge of mast cells, as shown by the PMA priming effect on fl-Hex release and paf biosynthesis. However, studies with cells depleted of PKC suggest that signals leading to paf biosynthesis can be also transduced via pathways independent from PKC.
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